Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.50 – $10.30
11% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $41.7K | $100.0K | $19.6K | $241.4K |
| Cost of revenue | $0 | $0 | $0 | $0 | $38.2K | $94.6K | $11.5K | $179.9K |
| Gross profit | $0 | $0 | $0 | $0 | $3.5K | $5.4K | $8.1K | $61.5K |
| Gross margin | — | — | — | — | 8.3% | 5.4% | 41.2% | 25.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$28.2K | −$26.8K | −$26.3K | −$90.7K | −$32.5K | −$7.1M | −$15.2M | −$545.7K |
| EBITDA | −$28.2K | −$26.8K | $0 | $0 | $0 | −$7.1M | −$15.2M | −$531.9K |
| Net income | −$30.3K | −$33.8K | −$35.9K | −$100.0K | −$34.0K | −$7.1M | −$15.2M | −$536.4K |
| Net margin | — | — | — | — | -81.7% | -7124.7% | -77610.4% | -222.2% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.20 | -0.38 | -0.01 |
Annual figures · source: Financial Modeling Prep
PANAMERA HOLDINGS CORP
No one on the platform currently holds PHCI.
No tracked institution reports a position in PHCI as of their last filing.
No one on the platform has traded PHCI yet.
| +0.00% |
| $1.2B |
| — |
| LTGHYLife Healthcare Group Holdings Limited | $2.49 | +0.81% | $891M | — |
| MDRXVeradigm Inc. | $5.00 | -1.96% | $849M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 474.7× sales vs its 1908.1× historical median P/S.
Fair value ≈ $10.05 · price $2.50 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.